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Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
17.06.2020 Genomewide 
association 
study of severe 
COVID-19 with 
respiratory 
failure 
NEJM | Article 
 Patients infected with 
SARS-CoV-2 show 
considerable variation 
in disease behaviour 
 This study involved 
1980 patients with 
C19 and severe 
disease (defined as 
respiratory failure) at 
7 hospitals in Italy 
and Spain 
 The 3p21.31 gene 
cluster was identified 
as a genetic 
susceptibility locus in 
patients with C19 with 
respiratory failure and 
confirmed a potential 
involvement of the 
ABO blood-group 
system 
Genetic 
susceptibility, 
respiratory 
failure 
 18.06.2020 Associations of 
global country 
profiles and 
modifiable risk 
factors with 
 medRxiv (non-
peer reviewed) 
| Article 
 Lifestyle modification 
could play a role in 
SARS-CoV-2 
infection and mortality 
but this has not be 
studied at a global 
level 
Obesity, 
physical 
inactivity, salt 
consumption 
2 
COVID-19 
cases and 
deaths 
 Analysing publicly 
available data from 
countries reporting 
C19 cases and 
deaths, obesity was 
the primary 
modifiable risk factor 
for infection and 
greater age, male 
sex, physical 
inactivity and low salt 
consumption were 
associated with 
excess deaths. 
Obesity was less 
influential on mortality 
than physical 
inactivity 
 High salt 
consumption may 
induce reductions in 
tissues ACE2 
expression and 
subsequently reduce 
mortality rates 
12.06.2020 The 
epidemiology 
and clinical 
characteristics 
of co-infection 
of SARS-CoV-
2 and influenza 
viruses in 
patients during 
the COVID-19 
outbreak 
J Medical 
Virology | Short 
Communication 
 A single-centred 
study of 307 SARS-
CoV-2 infected 
patients in Wuhan, 
China, (12 Jan to 21 
Feb 2020) 
 Co-infection of 
SARS-CoV-2 and 
influenza was 
common during the 
C19 outbreak 
 Patients co-infected 
with SARS-CoV-2 
and influenza B virus 
have a higher risk of 
developing poor 
outcomes 
influenza 
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Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
17.06.2020 Household 
secondary 
attack rate of 
COVID-19 and 
associated 
determinants in 
Guangzhou, 
China: a 
retrospective 
cohort study 
The Lancet 
Infectious 
Diseases | 
Article  
 Household 
transmissibility of 
SARS-CoV-2 remains 
unclear 
 This study uses a 
statistical transmission 
model to estimate the 
secondary attack rate 
of SARS-CoV-2 
among household and 
non-household close 
contacts in 
Guangzhou, China 
 SARS-CoV-2 is more 
transmissible in 
households that 
SARS-CoV and MERS 
 Older individuals 
(those 60y and older) 
are the most 
susceptible to 
household 
transmission of SARS-
CoV-2 
 Timely tracing and 
quarantine of close 
contacts should be 
implemented to 
prevent transmission 
during the viral 
incubation period 
Household, 
transmission 
16.06.2020 Effectiveness of 
isolation, 
testing, contact 
tracing, and 
physical 
distancing on 
reducing 
transmission of 
SARS-CoV-2 in 
different 
settings: a 
mathematical 
modelling study 
The Lancet 
Infectious 
Diseases | 
Article 
 A study of more than 
40 000 individuals to 
assess contact 
patterns and potential 
SARS-CoV-2 
transmission in 
different settings and 
to compare how 
combinations of self-
isolation, contact 
tracing, and physical 
distancing could 
reduce secondary 
cases. 
 The high 
transmissibility, the 
relative short serial 
Contact 
tracing, self- 
isolation, 
physical 
distancing, 
transmission 
4 
interval and 
asymptomatic 
transmission of SARS-
CoV-2 challenge 
effective isolation and 
contract tracing. This 
analysis estimated that 
a high proportion of 
cases would need to 
self-isolate and a high 
proportion of their 
contacts to be 
successfully traced to 
ensure an effective 
reproduction number 
lower than 1 in the 
absence of other 
measures. 
 Combining isolation 
and contact tracing 
with physical 
distancing measures, 
especially in settings 
where contact tracing 
would be difficult, 
could increase the 
likelihood of achieving 
sustained control of 
SARS-CoV-2 
transmission 
16.06.2020 The potential 
impact of 
COVID-19 in 
refugee camps 
in Bangladesh 
and beyond: A 
modelling study 
PLoS 
Medicine | 
Article 
 Using a dynamic 
model of SARS-CoV-2 
transmission, authors 
simulated how a C19 
outbreak could spread 
within the expansion 
site according to 3 
possible transmission 
scenarios (high, 
moderate, low) 
 Results show that a 
large scale outbreak is 
very likely in this 
setting after a single 
infectious person 
enters the camp 
 Hospitalisation 
capacity may be 
exceeded within 55-
136 days after 
introduction 
 Many approaches 
used to prevent and 
respond to C19 will not 
be practical in 
Refugee 
camps, 
transmission 
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humanitarian settings. 
Novel and untested 
strategies should be 
considered including 
innovative solutions to 
fill health workforce 
gaps 
15.06.2020 A novel cohort 
analysis 
approach to 
determining the 
case fatality 
rate of COVID-
19 and other 
infectious 
diseases 
PLoS ONE | 
Article 
 Authors claim that this 
model can be used far 
more effectively than 
current models to 
estimate the CFR 
during an outbreak, 
allow for better 
planning and to better 
understand the impact 
of individual 
interventions on the 
CFR 
CFR 
15.06.2020 Global, 
regional, and 
national 
estimates of the 
population at 
increased risk 
of severe 
COVID-19 due 
to underlying 
health 
conditions in 
2020: a 
modelling study 
Lancet Global 
Health| Article 
 Estimates suggest 1 in 
5 people worldwide 
(1.7 billion, 22% of the 
world's population) 
have an underlying 
health condition that 
could increase their 
risk of severe 
COVID19 if infected. 
 Finding from a 
modelling study with 
data from 188 
countries 
   
  
 
14.06.2020 Asymtomatic 
and 
presymptomatic 
transmission of 
SARS-CoV-2: 
A systematic 
review 
medRxiV 
(non-peer 
reviewed) | 
Systematic 
Review 
 This SR discusses and 
highlights the 
limitations of the 
literature on 
asymptomatic and 
presymtomatic 
transmission and 
proposes experiments 
that would provide a 
more definitive 
analysis of the relative 
role of presymptomatic 
and asymptomatic 
transmission in 
ongoing SARS-CoV-2 
pandemic 
 
6 
11.06.2020 Temperature, 
humidity, and 
latitude 
analysis to 
estimate 
potential 
spread and 
seasonality of 
coronavirus 
disease 2019 
(COVID-19) 
JAMA 
Infectious 
Diseases | 
Article 
 In a cohort of 50 cities 
with and without C19, 
areas with substantial 
community 
transmission of C19 
had distribution 
roughly along the 30o 
N to 50o N latitude 
corridor with 
consistently similar 
weather patterns 
(temperature and 
humidity), consistent 
with the behaviour of a 
seasonal respiratory 
virus 
 It may be possible, 
using weather 
modelling, to estimate 
regions most likely to 
be at higher risk of 
substantial community 
spread of C19 in the 
upcoming weeks to 
concentrate public 
health efforts 
weather 
Infection Prevention and Control 
Publicatio
n date 
Title/URL Journal/Article 
type 
Summary Keyword
s 
  
19.06.2020 Downsides of 
face masks 
and possible 
mitigation 
strategies: a 
systematic 
review and 
meta-analysis 
medRxiv (non-
peer reviewed) | 
Article 
 There is insufficient 
data to quantify all of 
the adverse effects 
that might reduce the 
acceptability, 
adherence and 
effectiveness of 
facemask 
 The downsides 
identified in this 
systematic review 
should aid 
approaches in 
mitigating problems 
(when, where and 
how of mask wearing 
or by mask redesign 
or substitution with 
alternatives such as 
face shields) and 
guide where the 
Face 
masks, 
mitigatio
n 
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benefits of masks 
outweigh the 
downsides 
 New research on 
facemasks should 
also assess and 
report the harms and 
downsides 
 Research is also 
urgently required on 
methods and designs 
to mitigate downsides 
of facemask wearing, 
especially face mask 
alternatives e.g. face 
shields 
18.06.2020 All hands on 
deck: a 
synchronized 
whole-of-world 
approach for 
COVID-19 
mitigation 
International 
Journal of 
Infectious 
Diseases | Pre-
proof 
 Presents a list of tools 
and entities to 
achieve maximum 
impact  
 The list is drawn from 
pandemic mitigation 
tools developed in 
response to past 
outbreaks including 
influenza, 
coronaviruses and 
Ebola 
 Highlights the role of 
political will, whole-of-
government 
approach, and the 
role of introducing 
mitigation measures 
early 
Mitigatio
n tools 
  
18.06.2020 Perceived 
challenges of 
COVID-19 
infection 
prevention and 
control 
preparedness: 
a multinational 
survey 
medRxiv (non-
peer reviewed) | 
Article 
 This study assessed 
the perceptions of 
HCWs on the current 
global IPC 
preparedness 
measures for C19 in 
339 IPC professionals 
spanning 63 countries 
in all 6 WHO regions, 
mostly from tertiary 
care centres 
 A lack of guidelines 
and concerns over 
insufficient PPE 
supply were evident 
in both HICs and LICs 
 National health 
authorities should 
“ramp up” IPC 
HCWs, 
PPE, 
guideline
s 
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implementation and 
focus on long-term 
preparedness for 
future pandemics 
18.06.2020 State-wise 
estimates of 
current hospital 
beds, intensive 
care unit (ICU) 
beds and 
ventilators in 
India: are we 
prepared for a 
surge in 
COVID-19 
hospitalisations
? 
medRxiv (non-
peer reviewed) | 
Article 
 This study combines 
data on public and 
private sector 
hospitals in India to 
produce state level 
estimates of hospital 
beds, ICU beds and 
mechanical 
ventilators. 
Assumptions made: 
5% of all hospital 
beds were ICU beds, 
50% of ICU beds 
were equipped with 
ventilators 
 Nationally, resources 
are concentrated in 
the private sector 
 There is substantial 
variation in available 
resources across 
states and union 
territories 
 In an optimistic 
scenario approx. 270 
000 ICU beds will be 
required, over 2.8 
times the estimated 
number available in 
India 
Hospital 
capacity, 
India 
 
15.06.2020 Clusters of 
Coronavirus 
Disease in 
Communities, 
Japan, 
January–April 
2020 
Emerging 
Infectious  Diseas
es |  
 Clusters of 
coronavirus 
infections are often 
linked to events 
many people 
breathe heavily 
while packed 
together, such as 
karaoke parties 
and and gym 
sessions, 
according to a 
survey in Japan. 
 Hitoshi Oshitani at 
Tohoku University 
in Sendai, Japan, 
and his colleagues 
analysed clusters 
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of at least five 
infected people 
who had all 
attended the same 
event or venue (Y. 
Furuse et al. 
Emerg. Inf. Dis. 
http://doi.org/ggz2h
g; 2020). Many of 
the 61 
‘superspreading’ 
incidents they 
identified occurred 
in hospitals, 
nursing homes and 
other care facilities, 
but a little more 
than half took 
place at venues 
such as musical 
events, restaurants 
and workplaces. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.06.2020 Combined 
point of 
care nucleic 
acid and 
antibody 
testing for 
SARS-CoV-
2: a 
prospective 
cohort 
study in 
suspected 
moderate to 
severe 
COVID-19 
disease 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Rapid C19 diagnosis in 
hospital is essential for 
patient management and to 
limit nosocomial 
transmission 
 This study assessed the 
diagnostic accuracy of 
combined rapid antibody 
point of care (POC) and 
nucleic acid assays for 
suspected C19 in the 
emergency department  
 Dual POC SARS-CoV-2 
testing can significantly 
improve diagnostic 
sensitivity whilst maintain 
high specificity 
 A rapid combined approach 
will aid recruitment into 
clinical trials and in 
prescribing therapeutics 
Nosocomial 
transmission, 
dual POC 
testing 
10 
18.06.2020 Detection of 
antibodies 
to the 
SARS-CoV-
2 spike 
glycoprotein 
in both 
serum and 
saliva 
enhances 
detection of 
infection 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Detecting antibody 
responses in hospitalised 
patients with severe disease 
is more reliable than in 
subjects with mild disease 
or in those who are 
asymptomatic 
 This could be due to the 
suboptimal sensitivity of 
antibody assays and the 
compartmentalisation of the 
antibody response 
 Detecting antibody 
responses in both saliva 
and serum is optimal for 
determining virus exposure 
and understanding immune 
responses after SARS-CoV-
2 infection 
Antibody, 
serum, saliva 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
16.06.2020 GM-CSF blockade 
with mavrilimumab 
in severe COVID-
19 pneumonia and 
systemic 
hyperinflammation: 
a single-centre, 
prospective cohort 
study 
The Lancet 
Rheumatology 
| Article 
 Treatment with 
mavrilimumab, an 
anti-granulocyte-
macrophage 
colony-stimulating 
factor receptor-a 
monoclonal 
antibody, was 
associated with 
improved clinical 
outcomes 
compared with 
standard care in 
non-mechanically 
ventilated patients 
with severe 
COVID-19 
pneumonia and 
systemic 
hyperinflammation 
 Treatment as well 
tolerated 
 Confirmation of this 
first preliminary 
evidence of a 
treatment effect of 
GM-CSF inhibition 
in COVID-
 mavrilimumab 
11 
19  supports further 
investigation 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.06.2020 Knowledge 
and 
behaviours 
related to 
the COVID-
19 
pandemic in 
Malawi 
medRxiv 
(non-peer 
reviewed) | 
Article 
 630 individuals (59% 
women, 77.6% residing in 
rural areas) aged 18 and 
older were interviewed by 
mobile phone between 25 
April and 23 May. Only 1 
respondent had never 
heard of C19 
 Misconceptions about the 
modes of transmission of 
SARS-CoV-2 and the 
course and severity of C19 
were common. Increased 
handwashing and avoiding 
crowds were the most 
reported strategies to 
prevent SARS-CoV-2 
spread. Use of face masks 
was more common in 
urban residents. 
 Gaps in knowledge about 
C19 persist in this 
population despite 
widespread access to 
information 
 Adoption of preventive 
strategies remains limited, 
possible due to limited 
perceived risk of infection 
among a large fraction of 
the population 
Knowledge, 
behaviour 
18.06.2020 Knowledge, 
attitudes 
and fear of 
COVID-19 
during the 
rapid rise 
period in 
Bangladesh 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Prospective, cross-
sectional survey of 2157 
subjects 13 to 90 years 
old, living in Bangladesh 
 Overall Bangladeshis 
reported a high prevalence 
of self-isolation, positive 
preventive health 
behaviours related to C19 
and moderate to high fear 
levels 
 Higher knowledge and 
practice was found in 
Knowledge, 
behaviour, 
attitude 
12 
males, higher education 
levels, older age and 
urban location 
 Fear of C19 was more 
prevalent in female and 
elderly subjects 
 Most reported a positive 
attitude reflecting the belief 
that COVID-19 was 
controllable and 
containable 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
July 2020 Coronavirus antibody tests have a 
mathematical pitfall 
Scientific 
American 
  
20.06.2020 Men’s health: COVID-19 pandemic 
highlights need for overdue policy action  
The Lancet | 
Comment 
Peter Baker 
Alan White 
Rosemary 
Morgan 
20.06.2020 Global governance for COVID-19 
vaccines 
The Lancet | 
Editorial 
  
18.06.2020 Humanitarian financing is failing the 
COVID-19 frontlines 
CGD | Blog Jeremy 
Konyndyk 
Patrick Saez 
Rose Worden 
18.06.2020 Women and girls are leading the way 
towards universal access to sexual and 
reproductive healthcare: will the global 
community follow? 
CGD | Blog Julia Kaufman 
17.06.2020 Hydroxychloroquine arm of Solidarity 
Trial stops 
WHO | News   
13 
16.06.2020 ‘We’ve got to be able to move more 
quickly.’ The pandemic reality of COVID-
19 clinical trials 
Science | News   
18.06.2020 WHO concerned over COVID-19 impact 
on women, girls in Africa 
WHO Africa | 
News 
  
18.06.2020 Imperial COVID-19 Vaccine Trial ICL | News   
18.06.2020 How Covid is making it tougher to tackle 
TB, AIDS, malaria and child health 
The Print  Jacob Bigio 
Madhukar Pai 
18.06.2020 African Parliamentarians aim for 
increased health budgets amid COVID-
19 pandemic 
African Union | 
News 
  
July 2020 Prioritising children’s rights in the 
COVID-19 response 
The Lancet Child 
& Adolescent 
Health | Editorial 
  
July 2020 COVID-19: a catalyst for flexibility and 
creativity in neurology 
The Lancet 
Neurology | 
Editorial 
  
17.06.2020 Household studies provide key insights 
on the transmission of, and susceptibility 
to, SARS-CoV-2 
The Lancet 
Infectious 
Diseases | 
Comment 
Virginia E. Pitzer 
Ted Cohen 
17.06.2020 Understanding the impact of COVID-19 
on essential medicine supply chains 
CGD | Blog Anthony 
McDonnell 
Kalipso 
Chalkidou 
Prashant Yadav 
Dan Rosen 
17.06.2020 Global Fund Survey: Majority of HIV, TB 
and malaria programs face disruptions 
as a result of COVID-19 
The Global Fund | 
News 
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16.06.2020 How deadly is the coronavirus? 
Scientists are close to an answer 
Nature | News Smriti Mallapaty 
16.06.2020 Case isolation, contact tracing, and 
physical distancing are pillars of COVID-
19 pandemic control, not optional 
choices 
The Lancet 
Infectious 
Diseases | 
Comment 
Chandini Raina 
MacIntyre 
16.06.2020 Delivering evidence-based critical care 
for mechanically ventilated patients with 
COVID-19 
The Lancet 
Respiratory 
Medicine | 
Comment 
Jorge I F Salluh 
Fernando Ramos 
Jean Daniel 
Chiche 
16.06.2020 GM-CSF in the treatment of COVID-19: 
a new conductor in the pathogenesis of 
cytokine storm? 
The Lancet 
Rheumatology | 
Comment 
Ennio Giulio 
Favalli 
Roberto Caporali 
15.06.2020 COVID-19: rethinking risk  The Lancet Global 
Health | Comment 
Nina Schwalbe 
Susanna 
Lehtimaki 
Juan Pablo 
Gutierrez 
June 2020 Food security in uncertain times The Lancet 
Planetary Health | 
Editorial 
  
15.06.2020 COVID-19 in Africa: between hope and 
reality 
Lancet Infectious 
Diseases | 
Correspondance 
Francine Ntoumi, 
Thirumalaisamy 
P Velavan 
15.06.2020 Providing Care for Pediatric Cancer 
Patients in the COVID-19 Era: Rapid 
Response Recommendations From a 
Developing Country  
Pediatric blood 
and cancer | 
Letter  
Mahmoud M 
Elzembely, 
Yousra S 
Abdelrahman, 
Shady Fadel, 
Hanafy Hafez 
15 
July 2020 Converging pandemics: implications of 
COVID-19 for the viral hepatitis 
response in sub-Saharan Africa 
Lancet 
gastroenterology 
and hepatology | 
Comment 
Neil Gupta, 
Hailemichael 
Desalegn, 
Ponsiano 
Ocama, 
Karine Lacombe, 
Richard Njouom, 
Mary Afihene et 
al. 
15.06.2020 Covid-19: Africa’s case numbers are 
rising rapidly, WHO warns 
BMJ | News Jacqui Thornton 
15.06.2020 Continuing Community Outreach in the 
face of Covid-19 
IDS | Opinion Sophie Boudre, 
Charlotte Morgan 
15.06.2020 COVID-19 lockdown in Zimbabwe: ‘we 
are good at surviving, but things are 
really tough’ 
zimbabweland Ian Scoones 
12.06.2020 Latin American scientists join the 
coronavirus vaccine race: ‘No one’s 
coming to rescue us’ 
Nature | news Emiliano 
Rodríguez Mega 
15.06.2020 World to hit 8 million confirmed 
coronavirus cases in next 24 hours 
New Scientist Adam Vaughan 
15.06.2020 How COVID-19 is reshaping priorities 
for both domestic resources and 
development assistance in the health 
sector 
UHC 2030 & 
SHFA | Blog 
Maria 
Skarphedinsdottir 
et al. 
12.06.2020 What we need is a sustainable politics of 
life 
The Lancet | 
Correspondence 
Tony Joakim 
Sandset 
Kristin Heggen 
Eivind 
Engebretsen 
16 
12.06.2020 COVID-19, nuclear war, and global 
warming: lessons for our vulnerable 
world 
The Lancet | 
Correspondence 
James E Muller 
David G Nathan 
12.06.2020 Gendered effects of school closures 
during the COVID-19 pandemic 
The Lancet | 
Correspondence 
Katarzyna 
Burzynska 
Gariela 
Contreras 
11.06.2020 Multigroup, adaptively randomised trials 
are advantageous for comparing 
coronavirus disease 2019 (COVID-19) 
interventions 
Annals of Internal 
Medicine | Ideas 
and Opinions 
Amalia S. 
Margaret et al. 
12.06.2020 Latin America and its global partners toil 
to procure medical supplies as COVID-
19 pushes the region to its limit 
JAMA | Medical 
News & 
Perspectives 
Rita Rubin 
Jennifer Abbasi 
Rebecca Voelker 
11.06.2020 The differential outcomes of coronavirus 
disease 2019 in low- and middle-income 
countries vs high-income countries 
JAMA Psychiatry | 
Viewpoint 
Daniel Vigo 
Lic Psych 
Graham 
Thornicroft 
Oye Gureju 
11.06.2020 Africa records over 200 000 COVID-19 
cases 
WHO Africa | 
News 
  
08.06.2020 Addressing COVID-19 outbreaks in 
socio-demographically challenging 
urban pockets: lessons from India 
Health Policy & 
Planning | Blog 
Saachi Dalal 
Ruchit Nagar 
Dr Dan Schwarz 
Rohit K. Singh 
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Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
16.06.2020 Low-cost 
dexamethasone 
reduces death by up 
to one third in 
hospitalised patients 
with severe 
respiratory 
complications of 
COVID-19 
RECOVERY 
Trial | 
Statement 
 Dexamethasone reduced 
deaths by one-third in 
ventilated patients and one 
fifth in other patients 
receiving oxygen only. 
There was no benefit for 
patients who did not require 
respiratory support. 
 1 death would be prevented 
by treatment of around 8 
ventilated patients or 
around 25 patients 
requiring oxygen alone 
 Given the public health 
importance of these results, 
full details will be published 
shortly 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Cytel  Serology-
based tests 
  Solidarity 
trial 
 COVID-
19 Oxford 
18 
Public 
Health 
for COVID-
19 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
19 
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
20 
COVID-19 
Digest 
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
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Sustainable 
Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
24-
25.06.2020 
Africa’s leadership 
role in COVID-19 
vaccine development 
and access 
Zoom webinar   African Union & Africa 
CDC 
18.06.20 2 
pm EDT 
Social, political, and 
public health factors 
fuelling the COVID19 
crisis in Brazil and 
Colombia 
Virtual event 45 mins Broad Global Health 
Initiative  
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
22 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
Online 
learning 
3 hours WHO 
23 
prevention, response 
and control 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
24 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based on 3 hours of 
desk-based research each day. The summary is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to decision 
makers which, if relevant to them, they should go to before making decisions. The HES are not intended to replace 
medical or professional advice and the researcher or the K4D consortium cannot be held responsible for any 
decisions made about COVID-19 on the basis of the HES alone. K4D services are provided by a consortium of 
leading organisations working in international development, led by the Institute of Development Studies (IDS), with 
Education Development Trust, Itad, University of Leeds Nuffield Centre for International Health and Development, 
Liverpool School of Tropical Medicine (LSTM), University of Birmingham International Development Department 
(IDD) and the University of Manchester Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for 
non-commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.   
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